Post-Webinar Survey Intelligence · Whitehat Cirrus
Optimizing Extended HPV Genotyping in Clinical Laboratories
CIRRUS
makes your
DATA SPEAK.
Survey Intelligence Report
n = 339 respondents · May 19, 2026
n = 339 respondents · May 19, 2026
Survey Respondents
339
of 551 attendees · 62% completion
Extremely Satisfied
46%
157 of 339 · zero dissatisfied
Marketing Consent
27%
91 opted in · actionable contacts
CE Credit Requested
95%
321 of 339 · PACE dominant
Active Buying Intent
36
labs in evaluation or planning
Attendee Satisfaction
Overall Satisfaction Rating
n = 339 respondents · single-select
97%
Extremely or Very Satisfied
0%
Dissatisfied
2%
Somewhat Satisfied
Whitehat Cirrus · Satisfaction Signal
97% of respondents rated the webinar as extremely or very satisfied; no respondent selected a dissatisfied rating. For a CE-accredited program covering technically dense content — multi-genotype assay validation, LoD methodology, and QC design — this distribution suggests the content was perceived as relevant and accessible by the attending audience. The 8 "Somewhat satisfied" responses (2%) align with the constructive comments on slide legibility and speaker pacing, indicating the minority friction was delivery-related rather than content-related. Implication: the satisfaction data is a reasonable indicator of program quality and audience fit; Fisher Healthcare may reference these figures in internal program reviews as one data point among broader measures of sponsorship value.
Content Value & Audience Purchasing Profile
Most Valuable Topics
Multi-select · % of 339 respondents selecting each topic
37%
Ongoing QC & Trend Monitoring
125 selected
35%
Validation Strategies
118 selected
32%
Clinical Rationale for Extended Genotyping
110 selected
32%
NAAT Technologies & Guidelines
108 selected
29%
Inspection Readiness Considerations
99 selected
Whitehat Cirrus · Content Resonance
Topic selection is strikingly even across all five content areas — a spread of only 8 percentage points from highest to lowest — indicating that the curriculum addressed a genuine breadth of need rather than a single dominant interest. Ongoing QC & Trend Monitoring and Validation Strategies leading narrowly at 37% and 35% respectively is consistent with the challenge data from registration: labs are not struggling with the clinical rationale for extended genotyping — they understand why. They are struggling with how to implement and sustain quality at the genotype level. The 29% selection rate for Inspection Readiness, while lowest, still represents 99 attendees actively concerned about regulatory defensibility — a commercially relevant segment for compliance-adjacent product positioning. Implication: Fisher Healthcare's product and content messaging should lead with implementation and QC support, not clinical rationale — the audience has already cleared that educational threshold.
Role in Purchasing Process
Multi-select · 293 of 339 responded
Whitehat Cirrus · Commercial Reach
While 60% of role-identified respondents report no direct purchasing involvement, the combined commercial-influence segment — decision makers (6%), influencers (25%), and information gatherers (18%) — reaches 49% of responding attendees. In a clinical laboratory context, "no part in purchasing" often understates commercial relevance: bench-level scientists who validate assays and flag QC failures are the upstream drivers of purchasing conversations, even without formal authority. The 17 self-identified decision makers represent a high-value direct contact segment within the 91 who consented to marketing communication. Implication: the consent list of 91 should be tiered — decision makers and influencers prioritized for direct outreach, information gatherers for nurture sequences.
GPO Affiliation
Named GPO affiliations · 274 responded
No GPO affiliation
206 · 75%
Vizient
27 · 10%
Premier
16 · 6%
HealthTrust
16 · 6%
Other / Unlisted GPO
9 · 3%
Whitehat Cirrus · GPO Signal
68 respondents (25% of those answering) carry active GPO affiliations, with Vizient leading at 27, followed by Premier and HealthTrust at 16 each. These three GPOs collectively represent the dominant contracting vehicles for acute care hospitals — the plurality lab setting in this audience. GPO-affiliated respondents are structurally more likely to be institutional buyers operating under contract constraints. Implication: Fisher Healthcare's existing GPO contract positioning — particularly with Vizient and Premier — is directly relevant to this audience segment and should be referenced in follow-up communications to affiliated respondents.
12-Month Implementation Intent
Does Your Lab Anticipate Changes to HPV Genotyping Practices Within the Next 12 Months?
Single-select · 285 of 339 responded
188
No Current Plans
66% of respondents
61
Possibly
21% of respondents
18
Yes — Under Evaluation
6% of respondents
18
Yes — Implementation Planned
6% of respondents
Combined active pipeline
Labs in evaluation or implementation
36 labs
Whitehat Cirrus · Intent & Pipeline
The 36 labs in active evaluation or planned implementation represent the highest-priority commercial segment from this program — a self-identified, time-bounded pipeline. An additional 61 respondents answered "Possibly," a category that in CE-webinar survey contexts consistently converts at meaningful rates when followed up with targeted educational content within 30–60 days of the live event. The 66% "No current plans" cohort should not be dismissed: in specialty molecular testing, "no current plans" often reflects budget cycle timing or institutional inertia rather than disinterest — this group attended a live CE event on the topic, which is itself a leading indicator of latent intent. Implication: a three-tier follow-up sequence — immediate outreach to the 36 active labs, nurture content to the 61 "Possibly" segment, and longer-cycle brand touchpoints to the no-plans cohort — maps directly to this intent distribution.
Engagement & Consent
Requested More Information
n = 339
Whitehat Cirrus · Information Demand
78 attendees (23%) explicitly requested more information — a high-intent signal distinct from passive consent. These respondents self-selected into a follow-up relationship and should be treated as the warmest outreach segment regardless of their purchasing role designation. Implication: this list of 78 should receive substantive follow-up content — not a generic thank-you — within 5 business days of the event.
Marketing Consent
Opted in to sponsor communications · n = 306 who answered
Whitehat Cirrus · Consent Quality
91 respondents (30% of those who answered the consent question) affirmatively opted into sponsor marketing communication. This is an explicitly consented list — a higher-quality asset than a raw registration list. Combined with the 78 who requested more information, the addressable follow-up universe for Fisher Healthcare is approximately 91–130 contacts depending on overlap. Implication: the consent list should be the foundation of any post-event CRM activity.
CE Credit Requested
Type of credit selected · n = 339
Whitehat Cirrus · CE Engagement
A 95% CE credit request rate (321 of 339) confirms that CE accreditation was a primary draw for this audience — not incidental. PACE dominates at 84% of credit requestors, with Florida CE at 4% and Certificate of Attendance at 12%. Implication: the PACE credential is load-bearing for this program's audience acquisition; it should be prominently featured in all future promotional materials for this series.
Attendee Comments
Selected Verbatim Comments
30 substantive comments of 339 respondents (9%) · curated by Whitehat Cirrus · amber border = constructive feedback
"Donna was very impressive in her ability to communicate her perspective, and she helped me understand implementation strategies and where the shortfalls may lie."
"Extremely insightful webinar! Thank you for sharing your expertise."
"BOTH speakers gave outstanding presentations. They were informative, timely, highly relevant."
"I knew some information about this topic but this webinar helped to further that understanding and teach me about some new technologies out there."
"Very clear and concise."
"Interesting topic, especially relating it to clinical lab practices 'in real time' to aid my understandings."
"I felt like the first speaker rushed too much through her part." ↑ Constructive · pacing
"Good course but how to integrate the home testing into a system of clinical testing and the actual implementation would have been very useful." ↑ Constructive · implementation depth
Whitehat Cirrus · Voice of Attendee
The qualitative comment record is overwhelmingly positive, with effusive praise for both speakers — notably Donna, who received individual recognition by name for her clarity on implementation strategies. The four constructive comments cluster around two actionable themes: slide legibility (font size, axis labels, zoom quality) and content pacing in the first presentation. Neither theme reflects dissatisfaction with the subject matter — both are production and delivery variables addressable in future sessions. The request for deeper implementation guidance on home testing integration signals a content gap that a follow-on webinar or whitepaper could directly fill. Implication: slide design standards and speaker pacing review should be standing agenda items in pre-production calls for future programs; the home testing integration thread is a validated content opportunity for a Part 2 session.
Notes & Sources
† Survey completion rate: 339 survey responses against 551 live attendees yields a 62% completion rate. Completion rates for CE-accredited webinars typically run higher than general webinar benchmarks due to the survey being embedded in the CE credit request workflow.
‡ Marketing consent denominator: 33 respondents left the consent question blank; the 27% figure uses the full 339 base. Using only the 306 who answered, the opt-in rate is 30%.
§ Purchasing role: Multi-select; respondents could select all applicable roles. Percentages are of the 293 who responded to the purchasing question. 46 respondents left the purchasing section blank.
¶ Topic selection: Multi-select; respondents could select all applicable topics. Percentages are of all 339 respondents. A blank topic selection is treated as non-response, not as "none selected."
∥ Comment curation: Substantive comments were selected by Whitehat Cirrus to represent the range of feedback; identical or near-identical thank-you responses were consolidated. All constructive feedback is represented in full.
‡ Marketing consent denominator: 33 respondents left the consent question blank; the 27% figure uses the full 339 base. Using only the 306 who answered, the opt-in rate is 30%.
§ Purchasing role: Multi-select; respondents could select all applicable roles. Percentages are of the 293 who responded to the purchasing question. 46 respondents left the purchasing section blank.
¶ Topic selection: Multi-select; respondents could select all applicable topics. Percentages are of all 339 respondents. A blank topic selection is treated as non-response, not as "none selected."
∥ Comment curation: Substantive comments were selected by Whitehat Cirrus to represent the range of feedback; identical or near-identical thank-you responses were consolidated. All constructive feedback is represented in full.